TWIRLA
Drug
Exeltis, USA Inc.
Total Payments
$14,079
Transactions
7
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $14,079 | 7 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,250 | 3 | 79.9% |
| Travel and Lodging | $2,785 | 3 | 19.8% |
| Food and Beverage | $43.96 | 1 | 0.3% |
Top Doctors Receiving Payments for TWIRLA
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Obstetrics & Gynecology | Webster, TX | $14,079 | 7 |
Ad
Manufacturing Companies
- Exeltis, USA Inc. $14,079
Product Information
- Type Drug
- Total Payments $14,079
- Total Doctors 1
- Transactions 7
About TWIRLA
TWIRLA is a drug associated with $14,079 in payments to 1 healthcare providers, recorded across 7 transactions in the CMS Open Payments database. The primary manufacturer is Exeltis, USA Inc..
Payment data is available from 2024 to 2024. In 2024, $14,079 was paid across 7 transactions to 1 doctors.
The most common payment nature for TWIRLA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,250, 79.9% of total).